Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Healthcare | 2.55% |
| 3 | Financials | 2.39% |
| 4 | Consumer Discretionary | 2.14% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
JELD-WEN Holding
JELD
$177M
| $7.38M | ﹤0.01% |
843,785
+749,101
| +791% | +$9.82M |
|
3152
CALL
Rocket Companies
RKT
$39.8B
| $7.38M | ﹤0.01% |
1,166,900
+242,500
| +26% | +$2.11M |
|
|
FHLT
3153
DELISTED
Future Health ESG Corp. Common stock
FHLT
| $7.37M | ﹤0.01% |
735,701
-11
| -0% | -$109 |
|
|
BRSL
3154
PUT
Brightstar Lottery PLC
BRSL
$2.08B
| $7.37M | ﹤0.01% |
466,500
-16,200
| -3% | -$303K |
|
3155
CALL
Medpace
MEDP
$17B
| $7.37M | ﹤0.01% |
46,900
+14,000
| +43% | +$2.23M |
|
3156
CALL
BioCryst Pharmaceuticals
BCRX
$2.57B
| $7.37M | ﹤0.01% |
584,900
+210,000
| +56% | +$2.7M |
|
3157
Cohen & Steers
CNS
$4.15B
| $7.37M | ﹤0.01% |
117,683
+5,474
| +5% | +$391K |
|
|
AONC
3158
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
| $7.37M | ﹤0.01% |
750,405
-226
| -0% | -$2.22K |
|
3159
PUT
Dover
DOV
$27.3B
| $7.37M | ﹤0.01% |
63,200
+42,400
| +204% | +$5.41M |
|
3160
CALL
Parker-Hannifin
PH
$126B
| $7.37M | ﹤0.01% |
30,400
-30,600
| -50% | -$8.28M |
|
3161
CALL
Sphere Entertainment
SPHR
$5.74B
| $7.36M | ﹤0.01% |
167,000
+80,200
| +92% | +$4.5M |
|
3162
CALL
Watsco Inc
WSO
$13.2B
| $7.36M | ﹤0.01% |
28,600
+18,000
| +170% | +$4.88M |
|
3163
Fortis
FTS
$28.7B
| $7.36M | ﹤0.01% |
193,733
+182,755
| +1,665% | +$8.27M |
|
3164
PUT
W.P. Carey
WPC
$16.4B
| $7.36M | ﹤0.01% |
107,613
+13,885
| +15% | +$1.14M |
|
|
SHAC
3165
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $7.36M | ﹤0.01% |
745,132
+2,243
| +0.3% | +$22.1K |
|
3166
CALL
Mid-America Apartment Communities
MAA
$15.3B
| $7.35M | ﹤0.01% |
47,400
-7,900
| -14% | -$1.36M |
|
3167
PUT
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.44B
| $7.35M | ﹤0.01% |
290,300
+73,100
| +34% | +$2.1M |
|
3168
PUT
United Therapeutics
UTHR
$22.7B
| $7.35M | ﹤0.01% |
35,100
+20,200
| +136% | +$4.52M |
|
3169
Sempra
SRE
$56B
| $7.35M | ﹤0.01% |
97,996
+60,450
| +161% | +$4.89M |
|
3170
PUT
LCI Industries
LCII
$2.56B
| $7.35M | ﹤0.01% |
72,400
+61,900
| +590% | +$7.52M |
|
3171
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.2B
| $7.33M | ﹤0.01% |
336,900
+266,039
| +375% | +$6.4M |
|
|
CDAQ
3172
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
| $7.33M | ﹤0.01% |
750,000
-507,321
| -40% | -$4.93M |
|
3173
Invesco Solar ETF
TAN
$1.3B
| $7.33M | ﹤0.01% |
99,515
+64,139
| +181% | +$5.18M |
|
3174
Triumph Financial Inc
TFIN
$1.77B
| $7.32M | ﹤0.01% |
134,648
+36,171
| +37% | +$2.38M |
|
|
CSII
3175
DELISTED
Cardiovascular Systems, Inc.
CSII
| $7.32M | ﹤0.01% |
527,778
+129,975
| +33% | +$1.93M |
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,858 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.